-
Malaria fight at a ‘tipping point,’ experts tell Congress
Leading global health experts told Capitol Hill lawmakers today that the fight against malaria is at a turning point, during a hearing on the US’ role in combating malaria globally.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health
-
Article examines global health policies and burden of disease on men
Socially responsible investing has long been associated with avoiding companies in "vice businesses" like alcohol, tobacco and weapons.
-
How three of the best-performing socially conscious funds are investing
Socially responsible investing has long been associated with avoiding companies in "vice businesses" like alcohol, tobacco and weapons.
- Categories
- Uncategorized
- Tags
- impact investing
-
Entrepreneurship and Social Impact in the Middle East — Business as Unusual?
It is a striking feature of the growing startup ecosystems in the Middle East that the lines between “entrepreneurship” and “social entrepreneurship” — that is, entrepreneurship that makes a social impact — often blur.
- Categories
- Impact Assessment
- Region
- South Asia
-
Anti-diarrhoea vaccine: Why social innovation is the way ahead for Indian healthcare
After nearly 25 years of work involving multi-institution, multi-country collaboration, India yesterday announced its first locally developed anti-diarrhoea vaccine.
- Categories
- Health Care
- Region
- South Asia
- Tags
- public health
-
What we can learn from one of the worst charities in the world
I normally hate to be critical of specific charities, but I’m going to make an exception because I’ve just found one of the worst charities in the world.
-
How To Be A Social Intrapreneur: Persistence, Resilience, and Patience
In working to turn her Brazilian bank into a financial resource for micro-entrepreneurs, Aparecida Teixeira de Morais has learned valuable lessons about changing a company from the inside.
- Categories
- Uncategorized
-
How Drug Companies Keep Medicine Out of Reach
The promise of delinking research and development from the actual manufacture of drugs, and why the pharmaceutical industry rejects an idea that could turn neglected diseases into profit
- Categories
- Health Care
- Tags
- public health
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.